Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

aTYR PHARMA (ATYR) Amortization of Deferred Charges (2019 - 2021)

Historic Amortization of Deferred Charges for aTYR PHARMA (ATYR) over the last 3 years, with Q4 2021 value amounting to $212000.0.

  • aTYR PHARMA's Amortization of Deferred Charges rose 7966.1% to $212000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $829000.0, marking a year-over-year increase of 1893.83%. This contributed to the annual value of $829000.0 for FY2021, which is 1893.83% up from last year.
  • As of Q4 2021, aTYR PHARMA's Amortization of Deferred Charges stood at $212000.0, which was up 7966.1% from $206000.0 recorded in Q3 2021.
  • In the past 5 years, aTYR PHARMA's Amortization of Deferred Charges ranged from a high of $235000.0 in Q2 2021 and a low of $118000.0 during Q4 2020
  • Its 3-year average for Amortization of Deferred Charges is $188083.3, with a median of $191000.0 in 2019.
  • In the last 5 years, aTYR PHARMA's Amortization of Deferred Charges tumbled by 3948.72% in 2020 and then soared by 7966.1% in 2021.
  • aTYR PHARMA's Amortization of Deferred Charges (Quarter) stood at $195000.0 in 2019, then plummeted by 39.49% to $118000.0 in 2020, then skyrocketed by 79.66% to $212000.0 in 2021.
  • Its Amortization of Deferred Charges was $212000.0 in Q4 2021, compared to $206000.0 in Q3 2021 and $235000.0 in Q2 2021.